File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Health State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia: A Systematic Review and Meta-Analysis

TitleHealth State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia: A Systematic Review and Meta-Analysis
Authors
KeywordsAsia
diabetes
meta-analysis
quality of life
systematic review
Issue Date2021
PublisherElsevier Inc. The Journal's web site is located at http://www.valueinhealthjournal.com/
Citation
Value in Health, 2021, v. 24 n. 7, p. 1059-1067 How to Cite?
AbstractObjectives: East and Southeast Asia has the greatest burden of diabetes in the world. We sought to derive a reference set of utility values for type 2 diabetes without complication and disutility (utility decrement) values for important diabetes-related complications to better inform economic evaluation. Methods: A systematic review to identify utility values for diabetes and related complications reported in East and Southeast Asia. We searched MEDLINE (OVID) from inception to May 26, 2020 for utility values elicited using direct and indirect methods. Identified studies were assessed for quality based on the National Institute of Health and Care Excellence guidelines. Utility and disutility estimates were pooled by meta-analyses with subgroup analyses to evaluate differences by nationality and valuation instrument. (PROSPERO: CRD42020191075). Results: We identified 17 studies for the systematic review from a total of 13 035 studies in the initial search, of which 13 studies met the quality criteria for inclusion in the meta-analyses. The pooled utility value for diabetes without complication was 0.88 (95% CI 0.83-0.93), with the pooled utility decrement for associated complications ranged from 0.00 (for excess BMI) to 0.18 (for amputation). The utility values were consistently more conservative than previous estimates derived in Western populations. Utility decrements were comparable for SF-6D and EQ-5D valuation instruments and for Chinese and other Asian groups. Conclusions: A reference set of pooled disutility and utility values for type 2 diabetes and its complications in East and Southeast Asian populations yielded more conservative estimates than Western populations.
Persistent Identifierhttp://hdl.handle.net/10722/299076
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 1.507
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMok, CH-
dc.contributor.authorKwok, HHY-
dc.contributor.authorNG, CS-
dc.contributor.authorLeung, GM-
dc.contributor.authorQuan, J-
dc.date.accessioned2021-04-28T02:25:52Z-
dc.date.available2021-04-28T02:25:52Z-
dc.date.issued2021-
dc.identifier.citationValue in Health, 2021, v. 24 n. 7, p. 1059-1067-
dc.identifier.issn1098-3015-
dc.identifier.urihttp://hdl.handle.net/10722/299076-
dc.description.abstractObjectives: East and Southeast Asia has the greatest burden of diabetes in the world. We sought to derive a reference set of utility values for type 2 diabetes without complication and disutility (utility decrement) values for important diabetes-related complications to better inform economic evaluation. Methods: A systematic review to identify utility values for diabetes and related complications reported in East and Southeast Asia. We searched MEDLINE (OVID) from inception to May 26, 2020 for utility values elicited using direct and indirect methods. Identified studies were assessed for quality based on the National Institute of Health and Care Excellence guidelines. Utility and disutility estimates were pooled by meta-analyses with subgroup analyses to evaluate differences by nationality and valuation instrument. (PROSPERO: CRD42020191075). Results: We identified 17 studies for the systematic review from a total of 13 035 studies in the initial search, of which 13 studies met the quality criteria for inclusion in the meta-analyses. The pooled utility value for diabetes without complication was 0.88 (95% CI 0.83-0.93), with the pooled utility decrement for associated complications ranged from 0.00 (for excess BMI) to 0.18 (for amputation). The utility values were consistently more conservative than previous estimates derived in Western populations. Utility decrements were comparable for SF-6D and EQ-5D valuation instruments and for Chinese and other Asian groups. Conclusions: A reference set of pooled disutility and utility values for type 2 diabetes and its complications in East and Southeast Asian populations yielded more conservative estimates than Western populations.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.valueinhealthjournal.com/-
dc.relation.ispartofValue in Health-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License-
dc.subjectAsia-
dc.subjectdiabetes-
dc.subjectmeta-analysis-
dc.subjectquality of life-
dc.subjectsystematic review-
dc.titleHealth State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia: A Systematic Review and Meta-Analysis-
dc.typeArticle-
dc.identifier.emailKwok, HHY: harleyk@hku.hk-
dc.identifier.emailLeung, GM: gmleung@hku.hk-
dc.identifier.emailQuan, J: jquan@hku.hk-
dc.identifier.authorityLeung, GM=rp00460-
dc.identifier.authorityQuan, J=rp02266-
dc.description.naturepostprint-
dc.identifier.doi10.1016/j.jval.2020.12.019-
dc.identifier.pmid34243830-
dc.identifier.scopuseid_2-s2.0-85103924814-
dc.identifier.hkuros322227-
dc.identifier.volume24-
dc.identifier.issue7-
dc.identifier.spage1059-
dc.identifier.epage1067-
dc.identifier.isiWOS:000670212100017-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats